Literature DB >> 36081969

Pulmonary Lymphangitic Carcinomatosis: An Atypical Presentation Leading to Discovery of Multi-Organ Metastasis With Unknown Occult Primary Malignancy.

Mustafa Al-Bayati1, Ola Al-Jobory1, Falah Abu-Hassan1, Basheer U Mohammed1, Sinan Yaqoob1, Omar Bazzaz2.   

Abstract

Pulmonary lymphangitic carcinomatosis is the spread of malignant cells to the lymphatic system in the lungs, which results in inflammation and lymphatic dilation. It is often found to coexist in patients with prior history of malignancy. The clinical presentation is usually related to respiratory symptoms, but atypical presentation can occur. Chest x-ray imaging can be non-revealing at initial stages, and abnormalities may only be appreciated when the disease gets to more advanced stages. Computed tomography imaging can reveal radiological abnormalities that were found to be associated with pulmonary lymphangitic carcinomatosis. More advanced imaging modalities and pathological tissue confirmation may be required for the diagnosis. However, once the diagnosis is made, prognosis remains poor and treatment efforts are geared towards the underlying malignancy. Here, we report on a rare case of pulmonary lymphangitic carcinomatosis in an adult male with no prior history of cancer, for whom his hospitalization led to the discovery of malignancy involving multiple organs.
Copyright © 2022, Al-Bayati et al.

Entities:  

Keywords:  liver masses; lymphangitic carcinomatosis; oncology; plc; pulmonary disease; pulmonary lymphangitic carcinomatosis; pulmonary metastasis

Year:  2022        PMID: 36081969      PMCID: PMC9441181          DOI: 10.7759/cureus.27705

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  7 in total

Review 1.  Lymphangitic carcinomatosis from prostate carcinoma.

Authors:  J W Wu; C Chiles
Journal:  J Comput Assist Tomogr       Date:  1999 Sep-Oct       Impact factor: 1.826

2.  Pulmonary lymphangitic carcinomatosis: diagnostic performance of HRCT and 18F-FDG-PET/CT in correlation to clinical pathologic outcome.

Authors:  Mario Jreige; Vincent Dunet; Igor Letovanec; John O Prior; Reto A Meuli; Catherine Beigelman-Aubry; Niklaus Schaefer
Journal:  J Nucl Med       Date:  2019-06-21       Impact factor: 10.057

3.  FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis.

Authors:  Priyanka Prakash; Mannudeep K Kalra; Amita Sharma; Jo-Anne O Shepard; Subba R Digumarthy
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

4.  Pulmonary Lymphangitic Carcinomatosis From Renal Cell Carcinoma.

Authors:  Leonard Riley; Nupur Verma; Tan-Lucien Mohammed; Ali Ataya
Journal:  Curr Probl Diagn Radiol       Date:  2018-07-23

5.  Pulmonary lymphangitis carcinomatosis: systematic review and meta-analysis of case reports, 1970-2018.

Authors:  Monika Klimek
Journal:  Postgrad Med       Date:  2019-04-05       Impact factor: 3.840

Review 6.  Pulmonary lymphangitic carcinomatosis in liver carcinoma: a rare case report and literature review.

Authors:  Li Zhuang; Xiangyan Liu; Chen Hu; Lin Zhang; Guoping Jiang; Jian Wu; Shusen Zheng
Journal:  World J Surg Oncol       Date:  2014-03-27       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.